C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2004
11/25/2004	CA2524470A1 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/25/2004	CA2524434A1 Benzyl sulfonamide derivatives as androgen receptor antagonists
11/25/2004	CA2523959A1 2-imidazo-benzothiazoles as adenosine receptor ligands
11/25/2004	CA2523431A1 Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases
11/24/2004	EP1479678A1 Pyrazole-derivatives as factor xa inhibitors
11/24/2004	EP1479676A1 Benzimidazole-derivatives as factor xa inhibitors
11/24/2004	EP1479674A1 Imidiazole-derivatives as factor xa inhibitors
11/24/2004	EP1479397A1 2,4,6-triamino-1,3,5-triazine derivative
11/24/2004	EP1479385A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/24/2004	EP1479373A1 Hair growth compositions and uses
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478634A1 Furanone derivatives
11/24/2004	EP1478630A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or -oxazoles
11/24/2004	EP1478629A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
11/24/2004	EP1478628A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478437A1 Acc inhibitors
11/24/2004	EP1478234A1 Synergistic insecticidal mixtures
11/24/2004	EP1263747B1 1,5-benzothiazepines and their use as hypolipidaemics
11/24/2004	EP0976732B1 1,4-substituted cyclic amine derivatives
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549809A Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1176915C Alkynyl phenyl heteroaromatic glucokinase activators
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6821994 A peroxisome proliferator activated receptor regulator, an oxazol-4-yl-methylfuran-2-yl-2-propenylthio- or sulfonyl- or sulfinyl-acetic acid or methyl ester
11/23/2004	US6821992 Fungicides
11/23/2004	US6821991 2-substituted thiazolidinones as β-3 adrenergic receptor agonists
11/23/2004	US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004	US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004	US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/18/2004	WO2004099201A1 Compounds as crf1 receptor antagonists
11/18/2004	WO2004099200A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
11/18/2004	WO2004099195A1 3-carbonylaminothiophenes and their use as fungicides
11/18/2004	WO2004099192A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099185A1 2-cyanopyrrolidine derivatives and their use as dpp-iv inhibitors
11/18/2004	WO2004099178A1 Chemical compounds
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099171A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099168A2 Substituted carboxylic acids
11/18/2004	WO2004099161A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004	WO2004099159A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	WO2004099155A2 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004	WO2004099147A1 Intermediate compound which is used for the preparation of pioglitazone
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004099127A1 Novel compounds as kinase inhibitors
11/18/2004	WO2004098610A1 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098498A2 Indole acetic acid derivatives and their use as pharmaceutical agents
11/18/2004	WO2004060879A3 Cyclization process for substituted benzothiazole derivatives
11/18/2004	WO2004054515A3 Thrombopoietin mimetics
11/18/2004	WO2004043954A3 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
11/18/2004	US20040229937 diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229925 reacting, in the presence of a palladium catalyst and a first solvent a 4,7-dihalo-2,1,3-benzothiadiazole with a thienyl group adding reagent, producing comonomer for polyfluroenes used as semiconductors
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229917 Imidazole derivatives
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229893 Substituted benzothiazole amide derivatives
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229876 Quinoline derivatives and quinazoline derivatives having azolyl group
11/18/2004	US20040229868 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229863 Administering 4-amino-azepan-3-one compound for inhibiting cathepsin S
11/18/2004	US20040229862 Imidazo-benzothiazoles
11/18/2004	US20040229861 CGRP receptor antagonists
11/18/2004	US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040228793 For scintigraphy imaging; selective accumulation in tumor cells/tissue
11/18/2004	DE10335782A1 Chromenonderivate Chromenonderivate
11/18/2004	CA2525195A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004	CA2525190A1 Intermediate compound which is used for the preparation of pioglitazone
11/18/2004	CA2524519A1 Compounds as crf1 receptor antagonists
11/18/2004	CA2524511A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
11/18/2004	CA2524508A1 3-carbonylaminothiophenes and their use as fungicides
11/18/2004	CA2524318A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	CA2523743A1 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523718A1 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523714A1 Substituted carboxylic acids
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/18/2004	CA2521580A1 Chemical compounds
11/17/2004	EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1476787A1 Visible radiation sensitive composition
11/17/2004	EP1476437A1 Novel tetrazole derivative useful as herbicides
11/17/2004	EP1476165A1 Substituted pyrimidinones and pyrimidinthiones
11/17/2004	EP1476162A1 Controlled synthesis of ziprasidone and compositions thereof
11/17/2004	EP1476151A1 1-arylsulfonyl-3-substitued indole and indoline derivates useful in the treatment of central nervous system disorders
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses

1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 628